90
Participants
Start Date
Not specified
Study Completion Date
March 31, 2000
Interferon alfa-2b
Didanosine
Memorial Sloan-Kettering Cancer Ctr., New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Univ. of Cincinnati CRS, Cincinnati
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Northwestern University CRS, Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
University of Colorado Hospital CRS, Aurora
Stanford CRS, Palo Alto
Bmc Actg Crs, Boston
Washington U CRS, St Louis
Puerto Rico-AIDS CRS, San Juan
Collaborators (2)
Schering-Plough
INDUSTRY
Bristol-Myers Squibb
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH